-
1 Comment
Zhejiang Jolly Pharmaceutical Co.,LTD is currently in a long term uptrend where the price is trading 25.4% above its 200 day moving average.
From a valuation standpoint, the stock is 56.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.2.
Zhejiang Jolly Pharmaceutical Co.,LTD's total revenue rose by 19.0% to $303M since the same quarter in the previous year.
Its net income has increased by 341.6% to $32M since the same quarter in the previous year.
Finally, its free cash flow grew by 56.9% to $108M since the same quarter in the previous year.
Based on the above factors, Zhejiang Jolly Pharmaceutical Co.,LTD gets an overall score of 5/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - General |
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE100001096 |
| Market Cap | 11B |
|---|---|
| Beta | 0.19 |
| PE Ratio | 20.28 |
| Target Price | 22 |
| Dividend Yield | 2.8% |
Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People's Republic of China and internationally. The company offers Wuling capsule that is used to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. It also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, the company offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, it provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, the company offers materials, such as cordyceps cephalosporium, fermented cordyceps, and Wuling powders. It also invests and participates in the medical services of Deqing No.3 People's Hospital. The company was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co.,LTD in 1998. Zhejiang Jolly Pharmaceutical Co.,LTD was founded in 1995 and is based in Huzhou, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300181.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
